Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum ProMIS Neurosciences Inc PMN

ProMIS Neurosciences Inc. is a clinical-stage biotechnology company. It is focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine applies a thermodynamic, computational... see more

NDAQ:PMN - Post Discussion

ProMIS Neurosciences Inc > PROXY VOTE AGAINST
View:
Post by goldtech on Sep 20, 2024 3:58pm

PROXY VOTE AGAINST

This financing was manipulated by Sphera and we need to vote against their warrants. This is the Company that naked shorted the shares and did a financing to suit their greedy needs. If the science works it will not matter and the Company can do a much better non dillutive financing, but the sad part is nobody has any financial wisdom.
Comment by FarmerBetsy on Sep 21, 2024 9:31am
Good luck goldtech a few Boston group shareholders will easily push this through they control this company. I don't understand the Sphera comments ? Total institutional shares at the time of last financing was 10.9%, will see 45 days after sep 30 updated numbers but i doubt much of a change. If Promis goes into the clinic testing alzheimers patients it will take many years to prove the ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities